IMGN
Immunogen Inc
IMGN
IMGN
Delisted
IMGN was delisted on the 9th of February, 2024.
204 hedge funds and large institutions have $1.1B invested in Immunogen Inc in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 69 reducing their positions, and 37 closing their positions.
Holders
204
Holders Change
+4
Holders Change %
+2%
% of All Funds
4.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
44
Increased
59
Reduced
69
Closed
37
Calls
$8.85M
Puts
$27.5M
Net Calls
-$18.7M
Net Calls Change
-$20.2M
Top Buyers
| 1 |
1
Capital Research Global Investors
Los Angeles,
California
|
$57.9M |
| 2 |
2
Renaissance Technologies
New York
|
$50.6M |
| 3 |
PC
3
PointState Capital
New York
|
$17.6M |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$68.3M |
| 5 |
5
Goldman Sachs
New York
|
$10.6M |
Top Sellers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$0 |
| 2 |
2
ClearBridge Investments
New York
|
$101M |
| 3 |
O
3
OrbiMed
New York
|
$15.8M |
| 4 |
4
Millennium Management
New York
|
$17.2M |
| 5 |
RG
5
Redmile Group
San Francisco,
California
|
$102M |
